MDXG - ミメディックス・グル―プ (MiMedx Group Inc) ミメディックス・グル―プ

 MDXGのチャート


 MDXGの企業情報

symbol MDXG
会社名 MiMedx Group Inc (ミメディックス・グル―プ)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ミメックス・グループ(MiMedx Group Inc.)は再生バイオ材料製品およびバイオインプラントヒト胎盤組織、皮膚および骨の統合された開発・加工・販売に従事する。再生医療材料セグメントには、創傷ケア、外科手術、スポーツ医学、眼科および歯科の市場カテゴリーのための製品および組織処理サービスの設計・製造・販売が含まれる。その生体材料プラットフォーム技術には、「AmnioFix」、「EpiFix」、「OrthoFlo」、「Physio」、「AlloBurn」、「CollaFix」などがある。「AmnioFix」と「EpiFix」は寄付された胎盤由来のヒト羊膜から加工されたその組織技術である。「OrthoFlo」は、同種の使用のための羊水由来同種移植片である。「Physio」は骨移植材料であり、骨組織にキャリアを添加していない。新しいブランド「CollaFix」は、修復を増強するために、筋骨格系組織の自然な構成、構造、および機械的特性を模倣するように設計されたコラーゲン繊維技術である。   ミメディックス・グル―プは米国のバイオ医療企業。再生生体材料製品とヒト羊膜を生体埋込処理された製品の開発、製造、販売に従事。寄贈された人間の胎盤を、様々な技術処理を通して羊膜を加工し、同種移植片を提供する。製品は創傷ケア、外科、スポ―ツ医学、眼科、歯科他、広範の医療分野で利用される。本社はジョ―ジア州。   
本社所在地 1775 West Oak Commons Court N.E. Marietta GA 30062 USA
代表者氏名 Charles R. Evans Charles R. Evans
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 770-651-9100
設立年月日 31229
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 690人
url www.mimedx.com
nasdaq_url https://www.nasdaq.com/symbol/mdxg
adr_tso
EBITDA EBITDA(百万ドル) 36.86000
終値(lastsale) 5.48
時価総額(marketcap) 608471104.04
時価総額 時価総額(百万ドル) 589.59520
売上高 売上高(百万ドル) 303.46800
企業価値(EV) 企業価値(EV)(百万ドル) 553.08220
当期純利益 当期純利益(百万ドル) 35.33400
決算概要 決算概要 BRIEF: For the nine months ended 30 September 2017 MiMedx Group Inc revenues increased 33% to $233.6M. Net income increased from $6.5M to $29.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Gain on divestiture increase from $0K to $4.3M (income) Amortization of intangible assets decrease of 23% to $1.5M (expense).

 MDXGのテクニカル分析


 MDXGのニュース

   Former MiMedx COO sentenced to year in prison  2021/02/24 23:53:04 Reuters
The former chief operating officer of biotech company MiMedx Group Inc was sentenced to a year in prison Wednesday after he was found guilty of conspiring to defraud investors by inflating the company's revenue.
   Prosecutors seek six-year prison term for former MiMedx CEO  2021/02/17 21:29:50 Reuters
Federal prosecutors have asked a judge to sentence Parker Petit, the former chief executive officer of biotech company MiMedx Group Inc, to six years in prison after he was found guilty of scheming to inflate the company's revenue.
   Europe Biofilms Treatment Market Size Will Reach Value & CAGR 7.9% between 2020 and 2027 | MiMedx, ConvaTec Group Plc, Coloplast Group, Hartman Group  2021/02/11 08:50:29 OpenPR
The Europe biofilms treatment market is expected to reach US$ 833.61million in 2027 from US$ 454.60million in 2019. The market is estimated to grow with a CAGR of 7.9% from 2020-2027. The “Europe Biofilms Treatment Market 2020 – 2027” of
   Former MiMedx CEO and COO are convicted on fraud, conspiracy charges  2020/11/20 12:43:55 Endpoints News
The MiMedx saga — which has included a months-long investigation, FBI involvement and allegations that the company fraudulently boosted its sales — has resulted in the conviction of two former executives. But it isn't quite over yet. Former CEO Parker
   Former MiMedx execs guilty of securities fraud, ending first white-collar NY federal trial since March  2020/11/19 21:57:46 Reuters
Two former executives of biotech company MiMedx Group Inc were found guilty on Thursday of scheming to inflate the company's revenue, ending the first white-collar criminal trial to begin in Manhattan's federal courthouse since the onset of the COVID-19 pandemic.
   Former MiMedx CEO and COO are convicted on fraud, conspiracy charges  2020/11/20 12:43:55 Endpoints News
The MiMedx saga — which has included a months-long investigation, FBI involvement and allegations that the company fraudulently boosted its sales — has resulted in the conviction of two former executives. But it isn't quite over yet. Former CEO Parker
   Former MiMedx execs guilty of securities fraud, ending first white-collar NY federal trial since March  2020/11/19 21:57:46 Reuters
Two former executives of biotech company MiMedx Group Inc were found guilty on Thursday of scheming to inflate the company's revenue, ending the first white-collar criminal trial to begin in Manhattan's federal courthouse since the onset of the COVID-19 pandemic.
   Former Chief Executive Officer And Chief Operating Officer Of Publicly Traded Biopharmaceutical Company Found Guilty Of Accounting Fraud  2020/11/19 19:13:20 US Department of Justice
Audrey Strauss, the Acting United States Attorney for the Southern District of New York, announced today that, following a four-week trial, PARKER H. “PETE” PETIT, the former chief executive officer of MiMedx Group, Inc. (“MiMedx”), a publicly traded biopharmaceutical company, was convicted of securities fraud, and WILLIAM TAYLOR, the former chief operating officer of MiMedx, was convicted of conspiracy to commit securities fraud, to make false statements in SEC filings, and to mislead the conduct of audits. The convictions stem from their participation in a scheme to fraudulently inflate MiMedx’s revenue.
   MiMedx To Present At Canaccord Genuity Virtual MedTech & Diagnostics Forum  2020/11/12 13:00:00 GlobeNewswire
MARIETTA, Ga., Nov. 12, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care…
   Biofilms Treatment Market New Innovation and Perception 2020: Organogenesis, ConvaTec Group, MiMedx Group, PAUL HARTMANN AG  2020/11/05 10:48:56 OpenPR
Biofilms Treatment Market Analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biofilms treatment market with detailed market
   Former MiMedx CEO and COO are convicted on fraud, conspiracy charges  2020/11/20 12:43:55 Endpoints News
The MiMedx saga — which has included a months-long investigation, FBI involvement and allegations that the company fraudulently boosted its sales — has resulted in the conviction of two former executives. But it isn't quite over yet. Former CEO Parker
   Former MiMedx execs guilty of securities fraud, ending first white-collar NY federal trial since March  2020/11/19 21:57:46 Reuters
Two former executives of biotech company MiMedx Group Inc were found guilty on Thursday of scheming to inflate the company's revenue, ending the first white-collar criminal trial to begin in Manhattan's federal courthouse since the onset of the COVID-19 pandemic.
   Former Chief Executive Officer And Chief Operating Officer Of Publicly Traded Biopharmaceutical Company Found Guilty Of Accounting Fraud  2020/11/19 19:13:20 US Department of Justice
Audrey Strauss, the Acting United States Attorney for the Southern District of New York, announced today that, following a four-week trial, PARKER H. “PETE” PETIT, the former chief executive officer of MiMedx Group, Inc. (“MiMedx”), a publicly traded biopharmaceutical company, was convicted of securities fraud, and WILLIAM TAYLOR, the former chief operating officer of MiMedx, was convicted of conspiracy to commit securities fraud, to make false statements in SEC filings, and to mislead the conduct of audits. The convictions stem from their participation in a scheme to fraudulently inflate MiMedx’s revenue.
   MiMedx To Present At Canaccord Genuity Virtual MedTech & Diagnostics Forum  2020/11/12 13:00:00 GlobeNewswire
MARIETTA, Ga., Nov. 12, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care…
   Biofilms Treatment Market New Innovation and Perception 2020: Organogenesis, ConvaTec Group, MiMedx Group, PAUL HARTMANN AG  2020/11/05 10:48:56 OpenPR
Biofilms Treatment Market Analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biofilms treatment market with detailed market

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ミメディックス・グル―プ MDXG MiMedx Group Inc)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)